Business

FDA Guidance on NUZ-001 IND Application

FDA Guidance on NUZ-001 IND Application

Neurizon Therapeutics LimitedFebruary 16, 20253
FDA Guidance on NUZ-001 IND Application

About this update from Neurizon Therapeutics Limited

Neurizon Therapeutics Limited has released a press release. View Attachment

View stock analysis, news, and events for Neurizon Therapeutics Limited

More from Neurizon Therapeutics Limited

All Neurizon Therapeutics Limited news →